UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
April 4, 2022
Accession Number:
0001104659-22-041024
Submission Type:
POS AM
CIK:
0001574232
Company Name:
Addex Therapeutics Ltd.
File Number:
333-262050